Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Growth 2021-2026
According to this latest study, the 2021 growth of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs will have significant change from previous year. By the most conservative estimates of global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2277.4 million in 2020. Over the next five years the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market will register a -1.7% CAGR in terms of revenue, the global market size will reach US$ 2126.3 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
5-HT3 Inhibitors
NK1 Inhibitors
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Acute CINV
Delayed CINV
Breakthrough CINV
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Heron Therapeutics
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Roche
Mylan
Baxter
GSK
Helsinn
Southwest Pharma
Haisco
Sun Pharma
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption 2016-2026
2.1.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption CAGR by Region
2.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Type
2.2.1 5-HT3 Inhibitors
2.2.2 NK1 Inhibitors
2.2.3 Others
2.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type
2.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sale Price by Type (2016-2021)
2.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Application
2.4.1 Acute CINV
2.4.2 Delayed CINV
2.4.3 Breakthrough CINV
2.4.4 Others
2.5 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application
2.5.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sale Price by Application (2016-2021)
3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Company
3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Company
3.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2019-2021)
3.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Company (2019-2021)
3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company
3.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2019-2021)
3.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sale Price by Company
3.4 Global Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Location Distribution
3.4.2 Players Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Region
4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Region
4.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region
4.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region
4.2 Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth
4.3 APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth
4.4 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth
4.5 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth
5 Americas
5.1 Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
5.1.1 Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021)
5.1.2 Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021)
5.2 Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type
5.3 Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region
6.1.1 APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2016-2021)
6.1.2 APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2016-2021)
6.2 APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type
6.3 APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Country
7.1.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021)
7.1.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021)
7.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type
7.3 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Country
8.1.1 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type
8.3 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors
10.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customer
11 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast
11.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Forecast by Region
11.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Forecast by Regions (2021-2026)
11.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Forecast by Type
11.7 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Forecast by Application
12 Key Players Analysis
12.1 Heron Therapeutics
12.1.1 Heron Therapeutics Company Information
12.1.2 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
12.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Heron Therapeutics Main Business Overview
12.1.5 Heron Therapeutics Latest Developments
12.2 Merck
12.2.1 Merck Company Information
12.2.2 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
12.2.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Merck Main Business Overview
12.2.5 Merck Latest Developments
12.3 Eisai
12.3.1 Eisai Company Information
12.3.2 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
12.3.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Eisai Main Business Overview
12.3.5 Eisai Latest Developments
12.4 Mundipharma
12.4.1 Mundipharma Company Information
12.4.2 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
12.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Mundipharma Main Business Overview
12.4.5 Mundipharma Latest Developments
12.5 Qilu Pharma
12.5.1 Qilu Pharma Company Information
12.5.2 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
12.5.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Qilu Pharma Main Business Overview
12.5.5 Qilu Pharma Latest Developments
12.6 Teva
12.6.1 Teva Company Information
12.6.2 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
12.6.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Teva Main Business Overview
12.6.5 Teva Latest Developments
12.7 Novartis
12.7.1 Novartis Company Information
12.7.2 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
12.7.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Novartis Main Business Overview
12.7.5 Novartis Latest Developments
12.8 Roche
12.8.1 Roche Company Information
12.8.2 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
12.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Roche Main Business Overview
12.8.5 Roche Latest Developments
12.9 Mylan
12.9.1 Mylan Company Information
12.9.2 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
12.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Mylan Main Business Overview
12.9.5 Mylan Latest Developments
12.10 Baxter
12.10.1 Baxter Company Information
12.10.2 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
12.10.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Baxter Main Business Overview
12.10.5 Baxter Latest Developments
12.11 GSK
12.11.1 GSK Company Information
12.11.2 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
12.11.3 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 GSK Main Business Overview
12.11.5 GSK Latest Developments
12.12 Helsinn
12.12.1 Helsinn Company Information
12.12.2 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
12.12.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Helsinn Main Business Overview
12.12.5 Helsinn Latest Developments
12.13 Southwest Pharma
12.13.1 Southwest Pharma Company Information
12.13.2 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
12.13.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Southwest Pharma Main Business Overview
12.13.5 Southwest Pharma Latest Developments
12.14 Haisco
12.14.1 Haisco Company Information
12.14.2 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
12.14.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Haisco Main Business Overview
12.14.5 Haisco Latest Developments
12.15 Sun Pharma
12.15.1 Sun Pharma Company Information
12.15.2 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
12.15.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Sun Pharma Main Business Overview
12.15.5 Sun Pharma Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of 5-HT3 Inhibitors
Table 3. Major Players of NK1 Inhibitors
Table 4. Major Players of Others
Table 5. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2021) & (M Units)
Table 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2016-2021)
Table 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2016-2021) & ($ million)
Table 8. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2016-2021)
Table 9. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sale Price by Type (2016-2021)
Table 10. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2021) & (M Units)
Table 11. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2016-2021)
Table 12. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Value by Application (2016-2021)
Table 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2016-2021)
Table 14. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sale Price by Application (2016-2021)
Table 15. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2019-2021) & (M Units)
Table 16. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Company (2019-2021)
Table 17. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company (2019-2021)
Table 19. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Producing Area Distribution and Sales Area
Table 21. Players Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
Table 22. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2016-2021) (M Units)
Table 26. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2016-2021)
Table 27. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2016-2021)
Table 29. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021) & (M Units)
Table 30. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2016-2021)
Table 31. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2016-2021)
Table 33. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2021) & (M Units)
Table 34. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2016-2021)
Table 35. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2021) & (M Units)
Table 36. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2016-2021)
Table 37. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2016-2021) & (M Units)
Table 38. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2016-2021)
Table 39. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2016-2021)
Table 41. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2021) & (M Units)
Table 42. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2016-2021)
Table 43. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2021) & (M Units)
Table 44. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2016-2021)
Table 45. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021) & (M Units)
Table 46. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2016-2021)
Table 47. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2016-2021)
Table 49. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2021) & (M Units)
Table 50. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2016-2021)
Table 51. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2021) & (M Units)
Table 52. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021) & (M Units)
Table 54. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2021) & (M Units)
Table 58. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2021) & (M Units)
Table 60. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Table 62. Key Application and Potential Industries of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Table 63. Key Challenges of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Table 64. Key Trends of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Table 65. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors List
Table 66. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customer List
Table 67. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Region (2021-2026) & (M Units)
Table 68. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Market Forecast by Region
Table 69. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2021-2026) & (M Units)
Table 72. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Region (2021-2026) & (M Units)
Table 74. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2021-2026) & (M Units)
Table 76. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2021-2026) & (M Units)
Table 78. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Type (2021-2026) & (M Units)
Table 80. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Application (2021-2026) & (M Units)
Table 84. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 87. Heron Therapeutics Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 89. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. Heron Therapeutics Main Business
Table 91. Heron Therapeutics Latest Developments
Table 92. Merck Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 94. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. Merck Main Business
Table 96. Merck Latest Developments
Table 97. Eisai Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 99. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 100. Eisai Main Business
Table 101. Eisai Latest Developments
Table 102. Mundipharma Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 104. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 105. Mundipharma Main Business
Table 106. Mundipharma Latest Developments
Table 107. Qilu Pharma Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 109. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 110. Qilu Pharma Main Business
Table 111. Qilu Pharma Latest Developments
Table 112. Teva Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 114. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 115. Teva Main Business
Table 116. Teva Latest Developments
Table 117. Novartis Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 119. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 120. Novartis Main Business
Table 121. Novartis Latest Developments
Table 122. Roche Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 124. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 125. Roche Main Business
Table 126. Roche Latest Developments
Table 127. Mylan Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 129. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 130. Mylan Main Business
Table 131. Mylan Latest Developments
Table 132. Baxter Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 134. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 135. Baxter Main Business
Table 136. Baxter Latest Developments
Table 137. GSK Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 139. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 140. GSK Main Business
Table 141. GSK Latest Developments
Table 142. Helsinn Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 144. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 145. Helsinn Main Business
Table 146. Helsinn Latest Developments
Table 147. Southwest Pharma Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 149. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 150. Southwest Pharma Main Business
Table 151. Southwest Pharma Latest Developments
Table 152. Haisco Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 154. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 155. Haisco Main Business
Table 156. Haisco Latest Developments
Table 157. Sun Pharma Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 159. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 160. Sun Pharma Main Business
Table 161. Sun Pharma Latest Developments
List of Figures
Figure 1. Picture of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Figure 2. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate 2016-2026 (M Units)
Figure 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of 5-HT3 Inhibitors
Figure 10. Product Picture of NK1 Inhibitors
Figure 11. Product Picture of Others
Figure 12. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type in 2020
Figure 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2016-2021)
Figure 14. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumed in Acute CINV
Figure 15. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market: Acute CINV (2016-2021) & (M Units)
Figure 16. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumed in Delayed CINV
Figure 17. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market: Delayed CINV (2016-2021) & (M Units)
Figure 18. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumed in Breakthrough CINV
Figure 19. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market: Breakthrough CINV (2016-2021) & (M Units)
Figure 20. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumed in Others
Figure 21. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market: Others (2016-2021) & (M Units)
Figure 22. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2016-2021)
Figure 23. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application in 2020
Figure 24. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market by Company in 2020 ($ Million)
Figure 25. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company in 2020
Figure 26. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Regions (2016-2021)
Figure 27. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region in 2020
Figure 28. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales 2016-2021 (M Units)
Figure 29. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue 2016-2021 ($ Millions)
Figure 30. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales 2016-2021 (M Units)
Figure 31. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue 2016-2021 ($ Millions)
Figure 32. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales 2016-2021 (M Units)
Figure 33. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue 2016-2021 ($ Millions)
Figure 34. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales 2016-2021 (M Units)
Figure 35. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue 2016-2021 ($ Millions)
Figure 36. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country in 2020
Figure 37. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country in 2020
Figure 38. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type in 2020
Figure 39. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application in 2020
Figure 40. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 41. Canada Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 42. Mexico Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 43. Brazil Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 44. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region in 2020
Figure 45. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Regions in 2020
Figure 46. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type in 2020
Figure 47. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application in 2020
Figure 48. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. Korea Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 51. Southeast Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 52. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 53. Australia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 54. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country in 2020
Figure 55. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country in 2020
Figure 56. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type in 2020
Figure 57. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application in 2020
Figure 58. Germany Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. France Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 60. UK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 61. Italy Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 62. Russia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 63. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country in 2020
Figure 64. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country in 2020
Figure 65. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type in 2020
Figure 66. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application in 2020
Figure 67. Egypt Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. South Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 69. Israel Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 70. Turkey Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 71. GCC Country Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
